Literature DB >> 21149812

Validation of consensus panel diagnosis in dementia.

Matthew J Gabel1, Norman L Foster, Judith L Heidebrink, Roger Higdon, Howard J Aizenstein, Steven E Arnold, Nancy R Barbas, Bradley F Boeve, James R Burke, Christopher M Clark, Steven T Dekosky, Martin R Farlow, William J Jagust, Claudia H Kawas, Robert A Koeppe, James B Leverenz, Anne M Lipton, Elaine R Peskind, R Scott Turner, Kyle B Womack, Edward Y Zamrini.   

Abstract

BACKGROUND: The clinical diagnosis of dementing diseases largely depends on the subjective interpretation of patient symptoms. Consensus panels are frequently used in research to determine diagnoses when definitive pathologic findings are unavailable. Nevertheless, research on group decision making indicates that many factors can adversely affect panel performance.
OBJECTIVE: To determine conditions that improve consensus panel diagnosis.
DESIGN: Comparison of neuropathologic diagnoses with individual and consensus panel diagnoses based on clinical scenarios only, fludeoxyglucose F 18 positron emission tomography images only, and scenarios plus images.
SETTING: Expert and trainee individual and consensus panel deliberations using a modified Delphi method in a pilot research study of the diagnostic utility of fludeoxyglucose F 18 positron emission tomography. PATIENTS: Forty-five patients with pathologically confirmed Alzheimer disease or frontotemporal dementia. MAIN OUTCOME MEASURES: Statistical measures of diagnostic accuracy, agreement, and confidence for individual raters and panelists before and after consensus deliberations.
RESULTS: The consensus protocol using trainees and experts surpassed the accuracy of individual expert diagnoses when clinical information elicited diverse judgments. In these situations, consensus was 3.5 times more likely to produce positive rather than negative changes in the accuracy and diagnostic certainty of individual panelists. A rule that forced group consensus was at least as accurate as majority and unanimity rules.
CONCLUSIONS: Using a modified Delphi protocol to arrive at a consensus diagnosis is a reasonable substitute for pathologic information. This protocol improves diagnostic accuracy and certainty when panelist judgments differ and is easily adapted to other research and clinical settings while avoiding the potential pitfalls of group decision making.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149812      PMCID: PMC3178413          DOI: 10.1001/archneurol.2010.301

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  A Delphi study to establish national cost-effectiveness research priorities for positron emission tomography.

Authors:  G Robert; R Milne
Journal:  Eur J Radiol       Date:  1999-04       Impact factor: 3.528

2.  What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.

Authors:  I Litvan; Y Agid; N Sastry; J Jankovic; G K Wenning; C G Goetz; M Verny; J P Brandel; K Jellinger; K R Chaudhuri; A McKee; E C Lai; R K Pearce; J J Bartko; N Sastrj
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

3.  More powerful procedures for multiple significance testing.

Authors:  Y Hochberg; Y Benjamini
Journal:  Stat Med       Date:  1990-07       Impact factor: 2.373

4.  Diabetes mellitus and the risk of dementia: The Rotterdam Study.

Authors:  A Ott; R P Stolk; F van Harskamp; H A Pols; A Hofman; M M Breteler
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

Review 5.  The use of clinical guidelines to improve medical practice: main issues in the United States.

Authors:  C Huttin
Journal:  Int J Qual Health Care       Date:  1997-06       Impact factor: 2.038

Review 6.  Consensus methods for medical and health services research.

Authors:  J Jones; D Hunter
Journal:  BMJ       Date:  1995-08-05

7.  The reproducibility of a method to identify the overuse and underuse of medical procedures.

Authors:  P G Shekelle; J P Kahan; S J Bernstein; L L Leape; C J Kamberg; R E Park
Journal:  N Engl J Med       Date:  1998-06-25       Impact factor: 91.245

Review 8.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

9.  The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis.

Authors:  J T Becker; F Boller; O L Lopez; J Saxton; K L McGonigle
Journal:  Arch Neurol       Date:  1994-06

10.  Consensus statement on genetic research in dementia.

Authors:  Marcel G M Olde Rikkert; Anco van der Vorm; Alistair Burns; Wim Dekkers; Philipp Robert; Norman Sartorius; Jacques Selmes; Gabriela Stoppe; Myrra Vernooij-Dassen; Gunhild Waldemar
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008-05-28       Impact factor: 2.035

View more
  12 in total

1.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

Review 2.  Consensus Approaches to Identify Incident Dementia in Cohort Studies: Systematic Review and Approach in the Successful Aging after Elective Surgery Study.

Authors:  Eyal Y Kimchi; Tammy T Hshieh; Ray Guo; Bonnie Wong; Margaret O'Connor; Edward R Marcantonio; Eran D Metzger; Jason Strauss; Steven E Arnold; Sharon K Inouye; Tamara G Fong
Journal:  J Am Med Dir Assoc       Date:  2017-09-18       Impact factor: 4.669

3.  Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes.

Authors:  Emily C Edmonds; Denis S Smirnov; Kelsey R Thomas; Lisa V Graves; Katherine J Bangen; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  Neurology       Date:  2021-08-10       Impact factor: 11.800

Review 4.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors:  Sam Gandy; Steven T DeKosky
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

5.  Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: results from a multicenter longitudinal database.

Authors:  Thomas D Koepsell; Dawn P Gill; Baojiang Chen
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12       Impact factor: 2.035

6.  Consensus-Based Attributes for Identifying Patients With Spasmodic Dysphonia and Other Voice Disorders.

Authors:  Christy L Ludlow; Rickie Domangue; Dinesh Sharma; H A Jinnah; Joel S Perlmutter; Gerald Berke; Christine Sapienza; Marshall E Smith; Joel H Blumin; Carrie E Kalata; Karen Blindauer; Michael Johns; Edie Hapner; Archie Harmon; Randal Paniello; Charles H Adler; Lisa Crujido; David G Lott; Stephen F Bansberg; Nicholas Barone; Teresa Drulia; Glenn Stebbins
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-08-01       Impact factor: 6.223

7.  Cohort Profile Update: Cognition and dementia in the Health and Aging in Africa Longitudinal Study of an INDEPTH community in South Africa (HAALSI dementia).

Authors:  Darina T Bassil; Meagan T Farrell; Ryan G Wagner; Adam M Brickman; M Maria Glymour; Kenneth M Langa; Jennifer J Manly; Joel Salinas; Brent Tipping; Stephen Tollman; Lisa F Berkman
Journal:  Int J Epidemiol       Date:  2022-08-10       Impact factor: 9.685

8.  Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study.

Authors:  Ron L H Handels; Pauline Aalten; Claire A G Wolfs; Marcel OldeRikkert; Philip Scheltens; Pieter Jelle Visser; Manuela A Joore; Johan L Severens; Frans R J Verhey
Journal:  BMC Neurol       Date:  2012-08-10       Impact factor: 2.474

9.  Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes.

Authors:  Ron L H Handels; Claire A G Wolfs; Pauline Aalten; Patrick M M Bossuyt; Manuela A Joore; Albert F G Leentjens; Johan L Severens; Frans R J Verhey
Journal:  BMC Neurol       Date:  2014-10-04       Impact factor: 2.474

10.  Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment.

Authors:  Stephanie L Garrett; Darius McDaniel; Malik Obideen; Antoine R Trammell; Leslie M Shaw; Felicia C Goldstein; Ihab Hajjar
Journal:  JAMA Netw Open       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.